$59.14-4.11 (-6.50%)
H.B.
H.B. Fuller Company in the Basic Materials sector is trading at $59.14 with a market capitalization of $3.4B. Wall Street consensus targets $73.00 (7 analysts), implying a +23.4% move over the next 12 months. The stock is currently 14% below its 52-week high of $68.63, remaining 1.7% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $770.84M↓ | $894.79M↑ | $892.04M↓ | $898.10M↑ | $788.66M |
| Gross Profit | $236.05M↓ | $282.08M↓ | $285.11M↓ | $286.38M↑ | $227.07M |
| Operating Income | $51.60M↓ | $121.25M↑ | $110.14M↑ | $100.04M↑ | $46.45M |
| Net Income | $21.05M↓ | $29.73M↓ | $67.16M↑ | $41.83M↑ | $13.25M |
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, He...
H.B. Fuller Co (FUL) reports robust financial performance with a 5.8% revenue increase and strategic acquisition plans to enhance growth and margins.
If you are wondering whether H.B. Fuller stock is genuinely good value or just fairly priced at current levels, the key is to look closely at what different valuation methods are saying about it. The share price last closed at US$64.60, with returns of 11.8% over the last 30 days, 7.1% year to date and 17.3% over the past year, giving investors a recent run worth putting into context. Recent coverage around H.B. Fuller has focused on its role in the broader materials sector and how investors...
If AMS accepts, HB Fuller says the deal would expand its total addressable market by $15bn, while bringing in around $300m in extra annual revenue for the adhesive specialist.
The Acquisition of Advanced Medical Solutions would broaden H.B. Fuller’s product portfolio and add a medical adhesives segment to its overall product offerings.
Investnigg.com -- U.S. adhesives manufacturer H.B. Fuller agreed to buy British medical supplier Advanced Medical Solutions in a cash deal valuing the company at around £715 million including debt, the latest in a string of overseas takeovers of London-listed companies.